PTPRC and melanoma: In melanomas with brain metastases the expression of cytotoxic T-lymphocyte-associated protein 4 (CTLA-4; CD152) detected in the immune cell (CD45+) ROIs was higher than in tumors without metastases or metastases at other sites.